Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:46:59 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:OSA from 2023-04-27 to 2024-04-26 - 22 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-26 16:05U:OSANews ReleaseProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
2024-03-15 20:01U:OSANews ReleaseProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
2024-02-22 08:30U:OSANews ReleaseProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
2024-02-20 16:05U:OSANews ReleaseProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
2024-01-30 08:00U:OSANews ReleaseProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
2024-01-29 08:00U:OSANews ReleaseProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
2024-01-08 08:00U:OSANews ReleaseProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea
2023-12-19 08:00U:OSANews ReleaseData Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices
2023-12-12 14:18U:OSANews ReleaseProSomnus CEO Len Liptak unveils game-changing device and promising clinical trial results for 2024
2023-11-09 16:17U:OSANews ReleaseProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results
2023-10-31 16:05U:OSANews ReleaseProSomnus Announces Third Quarter 2023 Investor Call and Business Update
2023-10-03 16:05U:OSANews ReleaseProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference
2023-09-21 08:30U:OSANews ReleaseProSomnus Raises $10 Million To Fuel Growth and Optimize Operations
2023-09-14 08:30U:OSANews ReleaseProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences
2023-08-23 08:00U:OSANews ReleaseUpdated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea
2023-08-03 08:10U:OSANews ReleaseProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results
2023-07-13 08:00U:OSANews ReleaseProSomnus to Design Head-to-Head Clinical Trial vs. Hypoglossal Nerve Stimulation
2023-07-06 08:29U:OSANews ReleaseProSomnus Announces Second Quarter 2023 Investor Call and Business Update
2023-06-28 08:00U:OSANews Release71% of Self-identified Snorers Have Never Consulted a Healthcare Professional
2023-06-08 16:08U:OSANews ReleaseData Presented at the 2023 SLEEP Annual Meeting Strengthens Evidence for ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea
2023-05-30 08:00U:OSANews ReleaseData Presented at the 2023 American Academy of Dental Sleep Medicine and the ‚  American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy ‚  for the Treatment of Obstructive Sleep Apnea
2023-05-09 16:00U:OSANews ReleaseProSomnus Reports First Quarter 2023 Financial Results